741 filings
Page 6 of 38
424B5
h3nplnop uwchbo
21 Apr 23
Prospectus supplement for primary offering
5:14pm
424B5
wq1vbrc
20 Apr 23
Prospectus supplement for primary offering
8:09am
8-K
lho 7qc4o9q58mnrb
17 Apr 23
Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023
11:09am
8-K
8x95l8
14 Apr 23
Departure of Directors or Certain Officers
5:01pm
4
w1446yh5
14 Apr 23
KINETA / CRAIG W. PHILIPS ownership change
4:12pm
4
3lo2fhmtuz
14 Apr 23
KINETA / Richard Peters ownership change
4:11pm
4
4nzu7vta0n dktivgar
14 Apr 23
KINETA / Pauline Kenny ownership change
4:10pm
4
m34 ifqsb
14 Apr 23
KINETA / Shawn Iadonato ownership change
4:09pm
4
zx2o epn4ku1y87ql36
14 Apr 23
KINETA / Thierry Guillaudeux ownership change
4:09pm
4
zujf1ysdyzmrv08h7z
14 Apr 23
KINETA / Marion R Foote ownership change
4:08pm
4
f12ozq
14 Apr 23
KINETA / Raymond J. Bartoszek ownership change
4:07pm
4
yrr4t8u1eb0e6w
14 Apr 23
KINETA / Keith Baker ownership change
4:06pm
4
7wuc cc6a
14 Apr 23
KINETA / David Arkowitz ownership change
4:06pm
8-K
wwq993r1o61mg cb9rz
12 Apr 23
Kineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors
7:01am
8-K
05rji
3 Apr 23
Kineta to Present at 22nd Annual Needham Healthcare Conference
7:01am
8-K
g6vd2hk
31 Mar 23
Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
8-K
bj2mc1is sluvm42hp7
31 Mar 23
Regulation FD Disclosure
12:00am
8-K
vt1zeu
22 Mar 23
Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023
7:00am
4
us3y v8drmv
21 Mar 23
KINETA / CRAIG W. PHILIPS ownership change
7:16pm